A gastric balloon, known as stomach balloon also, is an inflatable medical device that is temporarily placed into the stomach to reduce weight. It is marketed to provide weight loss when exercise and diet have failed and surgery is not wanted or not recommended. The balloon restricts the quantity of food in the belly can hold and creates thus an early on feeling of fullness and satiety. Less intake of food will lead to weight loss.

After up to half a year (or up to a year with some newer devices), the device is removed using endoscopy again. Longer stay of the balloon is not advised because of the threat of damage to the tissue wall and degradation of the balloon. The use of the balloon is complemented with counseling and nutritional advice or support.

Endoscopic placement of the balloon is temporary and reversible without surgical incisions. The (inter) gastric balloon for weight loss differs from the Sengstaken-Blakemore balloon used to avoid esophageal and gastric blood loss. The device will be used in patients with a body mass index greater than 27 kg/m2. It should not be employed to patients with certain intestinal problems such as inflammatory bowel disease or delayed gastric emptying, who are pregnant, or who are taking blood thinner medications such as Coumadin.

Low dosage aspirin (100 mg) is permitted. A 2016 meta analysis of studies showed short-term weight loss with no mortality. It was computed that the weight loss was 1.59 and 1.34 kg/m2 for overall and 3-month body mass index (BMI) reduction, respectively, and 4.6 and 4.77 kg/m2 for overall and 3-month weight reduction, respectively. Results are short term and inspired by the adherence to dietary and nutritional programs.

Long term studies lack. Gastric balloons are believed to be effective and safe in the brief run generally. There can be procedure-related side effects due to endoscopy and anesthesia. On an uncommon occasion the endoscopic keeping a balloon can result in death. Initial side ramifications of the balloon are common and may contain nausea, vomiting, reflux, and stomach cramps.

Other effects could be indigestion, bloating, diarrhea and flatulence. Rare side effects include esophagitis, gastric ulcer formation, or gastric perforation. These devices may become deflated and slip into the lower intestines. Migration of a balloon can result in bowel blockage, a surgical emergency. A couple of three FDA approved balloons in America Currently. These approved devices are placed via the esophagus using endoscopy. This is done in an outpatient placing under sedation. Once in place the balloon is filled up with saline, and remains as a free-floating object in the stomach cavity, too large to feed the pylorus.

In addition to saline, the balloon that is manufactured out of silicone may contain some radio-opaque materials as a radiographic marker and a dye such as methylene blue to notify the patient if the balloon leaks. Studies have suggested that fluid is more advanced than air for distending gastric balloons. Inflated balloons reduce the operative quantity capacity of the stomach. Gastric balloon devices have been approved in many countries, including in this Australia, Canada, Mexico, India, Guatemala, and many South and European American countries. They became available in the United States in 2015 when two different balloon devices were approved by the FDA.

  • 5 Foods to consume to Lose Weight Fast
  • Elevated mood
  • 9 Best Teas for Weight Loss
  • Patients must be in reasonable health insurance and able to properly go under a general anesthetic
  • Blood in vomitus

ReShape Integrated Dual Balloon System (ReShape Dual Balloon) is a double balloon device. The double balloon system is supposed to give a level of protection: when one balloon leaks or ruptures, blue dye in the urine will alert the individual that there is a nagging problem. Orbera contains an individual balloon device.

The Orbera system also reduced weight significantly when coupled with diet and exercise over a six months span. Spatz 3 Adjustable Intragastric Balloons (Dynamic – IGBs) are intragastric balloons have the ability to increase or decrease their volume. The Spatz adjustable balloon was introduced this year 2010 as the first IGB approved for 1-12 months implantation (beyond the united states), while offering an adjustability function that afforded balloon quantity changes as needed.